PubRank

Emi Ishikawa

Author PubWeight™ 16.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 2007 1.17
2 Hepatic arterial infusion chemotherapy using low-dose 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma. Oncology 2010 1.08
3 Des-γ-carboxyprothrombin may be a promising biomarker to determine the therapeutic efficacy of sorafenib for hepatocellular carcinoma. Dig Dis 2011 1.03
4 Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography. Oncology 2008 1.03
5 Regulatory failure of serum prohepcidin levels in patients with hepatitis C. Hepatol Res 2006 0.96
6 Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study. Oncology 2007 0.95
7 Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis. Dig Dis 2011 0.92
8 Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images. Oncology 2008 0.90
9 PIVKA-II is the best prognostic predictor in patients with hepatocellular carcinoma after radiofrequency ablation therapy. Oncology 2008 0.90
10 Non-invasive evaluation of hepatic fibrosis for type C chronic hepatitis. Intervirology 2010 0.88
11 Combination therapy with S-1 and pegylated interferon alpha for advanced hepatocellular carcinoma. Oncology 2008 0.88
12 A new prognostic staging system for hepatocellular carcinoma: value of the biomarker combined Japan integrated staging score. Intervirology 2008 0.85
13 Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult cases. Oncology 2010 0.84
14 Multiple tuberculous abscesses of the liver and the brain in a patient with acute leukemia. J Gastroenterol 2004 0.82
15 Elevated serum ALT levels during pegylated interferon monotherapy may be caused by hepatic iron overload. Intervirology 2008 0.82
16 Usefulness of the post-vascular phase of contrast-enhanced ultrasonography with sonazoid in the evaluation of gross types of hepatocellular carcinoma. Oncology 2010 0.79
17 Prolonged PEG-IFN and RBV is effective in patients with HCV genotype 1 and high viral load who achieved virological response later than 24 weeks. Intervirology 2010 0.77
18 Neoadjuvant epirubicin/docetaxel (ET) concomitant chemotherapy for primary breast cancer with tumor diameter >=3.1 cm: results of the Kyushu ET therapy phase II trial. Anticancer Res 2012 0.76
19 Weekly paclitaxel in the treatment of advanced or metastatic breast cancer previously treated or not treated with docetaxel: a phase II study. Chemotherapy 2005 0.75
20 PEG-IFNalpha/RBV combination therapy for chronic hepatitis C patients increases serum ferritin level while it improves sustained viral response rate. Intervirology 2010 0.75
21 Dose escalation study of epirubicin and docetaxel in patients with advanced or recurrent breast cancer. Chemotherapy 2008 0.75
22 [Docetaxel in combination with epirubicin as the first-line chemotherapy for advanced and recurrent breast cancer: a multicenter phase II study]. Gan To Kagaku Ryoho 2012 0.75